These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37013812)

  • 1. Thyroid Dysfunction in Periand Postmenopausal Women-Cumulative Risks.
    Frank-Raue K; Raue F
    Dtsch Arztebl Int; 2023 May; 120(18):311-316. PubMed ID: 37013812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction in perimenopausal and postmenopausal women.
    Pearce EN
    Menopause Int; 2007 Mar; 13(1):8-13. PubMed ID: 17448261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function and postmenopause.
    Schindler AE
    Gynecol Endocrinol; 2003 Feb; 17(1):79-85. PubMed ID: 12724022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for fracture in women with low serum levels of thyroid-stimulating hormone.
    Bauer DC; Ettinger B; Nevitt MC; Stone KL;
    Ann Intern Med; 2001 Apr; 134(7):561-8. PubMed ID: 12803168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of thyroid dysfunction on breast cancer risk: an updated meta-analysis.
    Tran TV; Kitahara CM; Leenhardt L; de Vathaire F; Boutron-Ruault MC; Journy N
    Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Kwak D; Ha J; Won Y; Kwon Y; Park S
    BMJ Open; 2021 May; 11(5):e043007. PubMed ID: 33986046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women.
    Morris MS
    Bone; 2007 Apr; 40(4):1128-34. PubMed ID: 17236836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
    Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
    Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.
    Spencer L; Bubner T; Bain E; Middleton P
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011263. PubMed ID: 26387772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Thyroid Dysfunction and the Thyroid-Stimulating Hormone Levels on the Risk of Atrial Fibrillation: A Systematic Review and Dose-Response Meta-Analysis from Cohort Studies.
    Huang M; Yang S; Ge G; Zhi H; Wang L
    Endocr Pract; 2022 Aug; 28(8):822-831. PubMed ID: 35660465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update.
    Floriani C; Gencer B; Collet TH; Rodondi N
    Eur Heart J; 2018 Feb; 39(7):503-507. PubMed ID: 28329380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
    Genazzani AR; Monteleone P; Giannini A; Simoncini T
    Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of thyroid hormone on skeletal integrity.
    Greenspan SL; Greenspan FS
    Ann Intern Med; 1999 May; 130(9):750-8. PubMed ID: 10357695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States.
    Inoue K; Tsujimoto T; Saito J; Sugiyama T
    Thyroid; 2016 Oct; 26(10):1457-1465. PubMed ID: 27539006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Subclinical Thyroid Dysfunction and Fracture Risk.
    Daya NR; Fretz A; Martin SS; Lutsey PL; Echouffo-Tcheugui JB; Selvin E; Juraschek SP
    JAMA Netw Open; 2022 Nov; 5(11):e2240823. PubMed ID: 36346629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Dysfunction and Cardiovascular Events in Patients With Dysglycemia.
    Shah R; Orlov S; Paré G; Gerstein HC;
    Can J Diabetes; 2023 Apr; 47(3):257-262. PubMed ID: 36858924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid disease in the perimenopause and postmenopause period.
    Uygur MM; Yoldemir T; Yavuz DG
    Climacteric; 2018 Dec; 21(6):542-548. PubMed ID: 30296186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.